Nucl Med Mol Imaging.  2013 Sep;47(3):201-204.

An Unusual Case of Anaphylaxis After Fluorine-18-Labeled Fluorodeoxyglucose Injection

Affiliations
  • 1Department of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. jjwalking@amc.seoul.kr
  • 2Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.

Abstract

[18F]FDG (fluorine-18 fluoro-2-deoxy-D-glucose) positron emission tomography (PET) is used worldwide for oncologic and neurologic applications. To date, the potential harm caused by [18F]FDG has focused on its radiation exposure effects rather than on its pharmacological effects. While an allergic response in the form of a skin manifestation has been reported after exposure to [18F]FDG, this report describes the first case of hypotension following exposure to this tracer. Here, the development of anaphylaxis after [18F]FDG injection is described.

Keyword

FDG; Anaphylaxis; Allergic

MeSH Terms

Anaphylaxis*
Hypotension
Positron-Emission Tomography
Skin Manifestations
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr